The Senate Health, Education, Labor and Pensions (HELP) Committee has advanced Marty Makary’s nomination as Commissioner of the Food and Drug Administration (FDA). Makary, a surgeon and public policy researcher at Johns Hopkins University, is a supporter of the Trump administration’s health agenda and a critic of COVID-19 lockdowns. Despite some initial resistance from Republican senators over Makary’s choice of top FDA counsel, he was still voted through 14-9.
The Great Stay: Why Tech Talent Is Choosing Stability Over Salary
How mass layoffs and economic anxiety have upended the talent war, turning “job hugging” into the public sector’s greatest opportunity to fill open tech positions.
